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ABSTRACT. Permanent His-bundle pacing has been gaining popularity in the adult population 
requiring cardiac resynchronization therapy. Initial procedural challenges are being overcome, 
and this method of pacing has been shown to improve left ventricular function and heart failure 
symptoms secondary to ventricular dyssynchrony. Though the etiologies of ventricular dyssyn-
chrony may differ in children and those with congenital heart disease than in adults with struc-
turally normal hearts, His-bundle pacing may also be a preferred option in these groups to restore 
more physiologic electric conduction and improve ventricular function. We present a review of the 
current literature and suggested directions involving deploying permanent His-bundle pacing in 
the pediatric and congenital heart disease population.
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Introduction
The typical electrical activation of the heart propagates 
as an electrical impulse that travels from the sinus node 
to the atrioventricular (AV) node, through the His–
Purkinje system, and to the ventricular myocardium. 
Conduction through the His–Purkinje system leads to a 
narrow QRS complex on the 12-lead electrocardiogram 
(ECG), representing synchronous left ventricular (LV) 
and right ventricular (RV) activation. In the setting of AV 
block, pacing of the ventricle (most commonly the RV) 
provides for an adequate ventricular heart rate. Chronic 
RV apical pacing leads to altered cardiac activation and 
mechanics with inherent left bundle branch (LBB) and 
ventricular dyssynchrony, resulting in reduced systolic 
function over time due to myocellular remodeling.1–5 
The RV septum and outflow tract have been explored 
as alternative pacing sites and seem to improve ejection 
fractions in adults as compared with RV apical pacing, 
although randomized trials have not shown any differ-
ences.6–9 With the advent of biventricular pacemakers, 
the resynchronization of ventricular activation has led to 
clear morbidity and mortality benefits in the adult popu-
lation. While effective in narrowing the QRS complex by 
creating a fused ventricular depolarization waveform, 
biventricular pacing is still unable to take advantage of 
the native His–Purkinje system and advantageous ven-
tricular myocyte orientation for optimal electrical signal 
transduction. Permanent His-bundle pacing is an alter-
native method that may better restore physiologic ven-
tricular activation.
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Anatomy
In the structurally normal heart, the sinus node is located 
in the high right atrium at the superior vena cava–right 
atrial junction and initiates electrical excitation of the 
myocardium. The electric impulse takes an inferior and 
leftward course through the right atrium until it reaches 
the AV node. The AV node is an atrial structure situated 
between the AV valves posterior to the aortic valve at the 
apex of the triangle of Koch (which is delineated by the 
coronary sinus orifice, the tendon of Todaro, and the sep-
tal leaflet of the tricuspid valve). The AV node exhibits 
decremental conduction to the bundle of His that pen-
etrates the AV plate, allowing for passage of the elec-
tric current to the ventricles. The electricity then travels 
through the bundle of His, in the membranous ventricu-
lar septum surrounded by insulating connective tissue. 
The bundle of His, though located in the membranous 
septum, is covered with myocardial fibers that travel 
through the membranous and muscular septum.10 This 
structure exits on the ventricular crest and travels to both 
bundle branches to deliver the electrical impulse to the 
LV and RV.11
Epicardial versus transvenous pacing leads
Pacemaker leads can be placed via a transvenous 
(Figures 1A and 1B) or epicardial (Figures 2A and 2B) 
route, which is largely determined by patient size and 
the presence of congenital heart disease (CHD). Adults 
with normal cardiac anatomy can typically accommodate 
a transvenous pacing system. Infants and young chil-
dren most commonly benefit from epicardial pacemaker 
leads as the innominate vein size limits the ability to 
accommodate a transvenous lead without increased risk 
of obstruction.12 Heightened incidence rates of venous 
occlusion and thrombosis and the need for reintervention 
are challenges seen when implanting transvenous pacing 
systems in young children, especially those weighing less 
than 10 kg.12,13 Moreover, a small subxiphoid approach 
is often sufficient for a dual-chamber epicardial system 
in an infant or young child, making this technique very 
feasible. In those with CHD, intracardiac shunts limit the 
utility of transvenous pacing systems due to the increased 
risk of thromboembolism.14,15
In adults with ventricular dyssynchrony benefiting from 
biventricular pacing, the LV lead is traditionally placed 
transvenously via the coronary sinus.16 When this route is 
felt not to be available, surgical epicardial lead placement 
is also an option. Less commonly, a transvenous LV endo-
cardial lead can be placed via a transseptal atrial punc-
ture to allow access to the left atrium and thus the LV. 
This approach would require systemic anticoagulation.17 
Small children with ventricular dyssynchrony are not 
able to accommodate a pacemaker lead in the coronary 
sinus or descending coronary veins and so commonly 
receive epicardial leads if biventricular pacing is desired.
Cardiac resynchronization therapy in adults: 
biventricular and His-bundle pacing
Medical management for adults with chronic heart failure 
has improved morbidity and mortality rates; however, 
outcomes remain suboptimal.18–20 Cardiac resynchroni-
zation therapy (CRT) using a biventricular pacemaker 
increases LV ejection fraction, improves symptoms, qual-
ity of life, and decreases mortality for those with heart 
failure and ventricular dyssynchrony.21–24
His-bundle pacing is an alternative to biventricular pac-
ing to restore ventricular synchrony. The goal of His-bun-
dle pacing is to achieve physiologic ventricular activation 
where it otherwise cannot exist. This can be in cases of 
Figure 1: A: Anteroposterior chest radiograph showing lead placement in a dual-chamber transvenous pacing system in a 
structurally normal heart. B: Lateral chest radiograph showing lead placement in a dual-chamber transvenous pacing system 
in a structurally normal heart.
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AV block (whether located at the AV node, proximal His 
bundle, or distal His bundle) requiring RV pacing or in 
patients with LBBB (whether surgical or myopathic). In 
the setting of permanent AV block, conventional endocar-
dial pacing systems result in an obligate paced left LBBB 
morphology QRS, and these individuals are at a higher 
risk for ventricular dyssynchrony with decreased LV sys-
tolic function. As such, His-bundle pacing rather than RV 
myocardial pacing produces a physiologic narrow com-
plex ventricular depolarization, which improves ejection 
fraction.
The feasibility of permanent His-bundle pacing was first 
demonstrated in canines by Karpawich et al. in 1992.25 
Then, permanent His-bundle pacing was first demon-
strated in humans in 2000 by Deshmukh et al.26 They 
described His-bundle pacing in 18 adults with chronic 
atrial fibrillation and dilated cardiomyopathy with a 
narrow QRS complex. Successful His-bundle pacing was 
accomplished in the majority of patients and improve-
ment in LV function was seen in nine of those individuals 
who maintained His-bundle capture. Since this publica-
tion, multiple other studies have shown that His-bundle 
pacing leads to better ventricular function, improvement 
in New York Heart Association (NYHA) functional class, 
and a higher quality of life when compared with RV 
pacing.27,28
Patients who require a high percentage of ventricular 
pacing and thus who are at a high risk for developing 
pacemaker-induced cardiomyopathy may be individuals 
who will benefit the most from His-bundle pacing. Adult 
studies have demonstrated that these are patients with 
AV conduction disease and an otherwise narrow QRS 
complex, those with permanent atrial fibrillation, and 
those with failed biventricular CRT device implants.29 
Similarly, individuals with profound LBBB and electrical 
and mechanical ventricular dyssynchrony are expected 
to regain a narrow complex QRS with His-bundle pacing 
and possible LV systolic function benefit. His-bundle pac-
ing has been gaining acceptance in the adult population 
and may be a more ideal way to accomplish resynchroni-
zation in children who are too small to allow access to the 
coronary sinus for placement of an LV lead.
Classification of His-bundle pacing
His-bundle pacing is accomplished either by direct stim-
ulation of the His bundle (selective His-bundle pacing) 
or by stimulation of the His bundle and the surrounding 
ventricular tissue, defined as nonselective His-bundle 
pacing. There are published criteria to differentiate 
the two types of His-bundle pacing; essentially, selec-
tive His-bundle pacing results in His-bundle capture 
at low outputs and does not stimulate the ventricular 
myocardium as the His bundle is in direct contact with 
only the membranous septum, not the myocardium.28,29 
Meanwhile, nonselective His-bundle pacing, may require 
higher outputs to stimulate the His bundle and involves 
ventricular capture due to placement of the lead closer 
to the ventricular myocardium.28 Both methods of His-
bundle pacing should result in a narrower QRS complex 
as compared with isolated ventricular myocardial pacing 
(Figures 3A–3C).
Procedure
At present, the SelectSecure MRI SureScan 3830 trans-
venous lead (Medtronic, Minneapolis, MN, USA) is the 
only lead approved by the Food and Drug Administration 
for His-bundle pacing. This is a bipolar, nonretractable 
Figure 2: A: Anteroposterior chest radiograph showing lead placement of a bipolar dual-chamber epicardial pacing system in 
a structurally normal heart. B: Lateral chest radiograph showing lead placement of a bipolar dual-chamber epicardial pacing 
system in a structurally normal heart.
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screw-in lead delivered via preformed catheters. An 
access sheath (7-French or larger) may be placed first to 
preserve vascular access following catheter removal in 
the event that final lead testing parameters are subopti-
mal, although this step is optional. The C315 His catheter 
(Medtronic, Minneapolis, MN, USA) is used to guide 
the transvenous lead into the correct position at the His 
bundle. The pacing lead is turned clockwise four to five 
times to affix the His-bundle helix. Sensing characteristics 
are tested and, if the transvenous lead is deemed to be 
Figure 3: A: Selective His-bundle pacing in a patient with a structurally normal heart. B: Nonselective His-bundle pacing in a 
patient with LTGA. C: RV pacing in a structurally normal heart with a resultant LBBB pattern.
Permanent HBP in Pediatrics and CHD
The Journal of Innovations in Cardiac Rhythm Management, February 2020 4008
in the appropriate position at the His bundle, a high-fre-
quency His potential can be noted prior to the current of 
injury. When pacing is activated, a narrow, native QRS 
complex should be noted, indicating ideal placement 
of the His-bundle lead. An LBBB pacing morphology 
would indicate RV capture or right bundle branch cap-
ture. A fusion complex indicates nonselective His-bundle 
pacing, involving fused RV and His-bundle activation. 
Some providers have recently achieved LBB capture for 
resynchronization, which would result in a right bundle 
branch morphology.30
Once the His-bundle lead is in place, additional leads 
may be placed in a conventional fashion. For those who 
could benefit from resynchronization by way of His-bun-
dle pacing, our preferred method for lead placement is 
to place an additional RV lead, particularly in the event 
of elevated His-lead threshold values. Finally, a lead is 
positioned in the right atrial appendage. All lead char-
acteristics are retested through the CRT device with the 
His-bundle lead connected to the “left ventricular” port. 
Figures 4A and 4B demonstrate His-bundle lead place-
ment when compared with the traditional RV dual-cham-
ber transvenous pacemaker lead placement shown in 
Figures 1A and 1B.
Challenges of His-bundle pacing
There are inherent challenges in optimal lead placement 
in His-bundle pacing: as an example, the membranous 
septum is thin and multiple attempts to screw in a lead 
can potentially result in perforation, although no cases 
of such have definitively been reported in the literature. 
Precise lead placement is needed to pace the His bundle 
at low outputs as opposed to the potential of requiring 
higher outputs with nonselective His-bundle pacing.28,29 
However, experience in lead placement in adults is 
increasing and has been demonstrated to be safe and 
effective, with a success rate of 80% reported in one study 
by Sharma et al.4 More work needs to be done, however, 
regarding utilizing this technology in the pediatric and 
CHD populations.
Application in pediatrics and congenital heart 
disease
Anatomy of the conduction system in congenital 
heart disease
The positions of the AV node and bundle of His in certain 
congenital heart lesions differ from those in the structur-
ally normal heart due to alterations in the embryologic 
migration of the four specialized myocardial rings that 
form the progenitor cardiac conduction system. As an 
example, in the context of a double-inlet LV, the AV node 
and bundle of His are displaced rightward where the AV 
valve ring meets the crest of the ventricular septum. In 
cases of congenitally corrected transposition of the great 
arteries, the AV node is displaced superiorly and right-
ward of the pulmonary valve, while the bundle of His 
travels anterosuperiorly to the pulmonary infundibu-
lum.31 Those with right atrial isomerism often have two 
distinct AV nodes (ie, two distinct physical structures, not 
merely dual AV node physiology) conducting electricity 
to separate the bundle of His tissues.32 In patients with AV 
septal defects, the AV node is displaced posteroinferiorly 
between the atria and outside the triangle of Koch.33 All 
of these anatomic variations must be taken into consider-
ation and may add procedural complexity when attempt-
ing to place a His-bundle pacemaker lead in patients with 
these congenital heart defects.
Pacemaker lead placement
Data regarding optimal pacemaker lead sites are varied 
in pediatric patients. Janousek et al. studied the use of 
Figure 4: A: Anteroposterior chest radiograph showing lead placement in a His-bundle pacing system in a patient with a struc-
turally normal heart. B: Lateral chest radiograph showing lead placement in a His-bundle pacing system in a patient with a 
structurally normal heart.
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different pacing sites in 178 children with AV block and 
structurally normal hearts and found that pacing the LV 
apex or the LV midlateral wall resulted in higher short-
ening fraction and ejection fraction than when using any 
RV pacing site.8 Karpawich et al. in 2015 assessed various 
pacing sites along the RV septum and apex in patients 
with and without CHD, finding that 38% of cases showed 
optimal contractility when paced at the RV midseptum; 
however, in this cohort, among patients with CHD, the 
optimal pacing site varied significantly.34 The difference 
in results between these studies is likely accounted for by 
the different populations (with versus without CHD) and 
the variation in pacing sites. The heterogeneity in pediat-
ric patients with CHD likely necessitates an individual-
ized approach to ventricular pacing sites.
Epicardial leads may be favored in those with CHD who 
have residual shunt lesions, as transvenous systems may 
increase the risk of paradoxical emboli.14,15 In those with 
altered systemic venous anatomy—for example, those 
palliated with a cavopulmonary connection Fontan pro-
cedure—transvenous pacing is not optimal in the absence 
of systemic anticoagulation. As previously discussed, 
small children typically require epicardial leads as their 
systemic veins are not large enough to accommodate a 
transvenous pacing system. In regard to CRT in the pedi-
atric population, this is often achieved with epicardial 
lead placement.
Cardiac resynchronization therapy in pediatrics
The indications and efficacy of CRT in pediatrics and 
those with CHD are yet to be fully characterized. These 
populations differ from adults potentially due to the 
longer overall duration of pacemaker dependence and 
difference in anatomic substrate in the case of CHD. A 
study conducted in 2005 by Dubin et al. retrospectively 
assessed biventricular pacing in patients younger than 
21 years of age or who had CHD. The majority of patients 
in this study had reduced LV systolic function and CHD, 
which differs from the profile of the typical adult patient 
requiring CRT. It was determined that CRT was benefi-
cial in improving ejection fraction and shortening QRS 
duration in these populations.35 A subsequent study con-
ducted by Janousek et al. concluded that pacemaker-in-
duced cardiomyopathy in the setting of CHD or pediatric 
status is the most significant indication for CRT therapy.36 
This study found that, of those with CHD, individuals 
with a systemic LV had the most improvement in ejec-
tion fraction and the largest decrease in the LV end-di-
astolic dimension. The second significant predictor of 
CRT success was a higher grade of initial systemic AV 
valve regurgitation, which improved after CRT pacing. 
As such, while indications may differ in pediatrics and 
in those with CHD, there may indeed be a benefit to CRT 
in select groups. Regardless of the substrate, CRT is indi-
cated in those who do have ventricular dyssynchrony 
leading to altered cardiac mechanics.
His-bundle pacing in pediatrics and congenital 
heart disease
While His-bundle pacing is being used with increasing 
frequency in adult patients, experience with its applica-
tion in pediatric patients and those with CHD has been 
more limited. In contrast to adults, pediatric patients face 
considerations such as a longer duration of pacing, ana-
tomic size limitations that may impact the choice of pace-
maker device, and ongoing somatic growth. This subset of 
patients who experience ventricular dyssynchrony from 
long-term pacing or who are too small to accommodate a 
coronary sinus lead for biventricular pacing may benefit 
from His-bundle pacing to restore ventricular synchrony. 
Data in this population, however, are currently lacking.
Children with CHD—another special population—are 
surviving longer into adulthood due to improved sur-
gical and medical treatments but are also now experi-
encing secondary long-term complications in greater 
numbers, including heart failure and ventricular 
dyssynchrony.37 While adult criteria to initiate CRT 
can be extrapolated to pediatric and congenital heart 
Figure 5: A: Anteroposterior chest radiograph showing lead placement in a His-bundle pacing system in a patient with LTGA. 
B: Lateral chest radiograph showing lead placement in a His-bundle pacing system in a patient with LTGA.
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populations in certain circumstances, this strategy has 
clear limitations in generalizing results to a different 
population. At present, many patients with CHD are 
treated with CRT to prevent complications associated 
with chronic RV pacing.38
As noted previously, those with CHD also have special 
anatomic considerations. The AV node in these patients 
may be displaced in certain lesions, while transvenous 
access to the coronary sinus may not be possible for 
biventricular pacing. The successful implantation of a 
His-bundle pacemaker has been described before in an 
adult patient with L-transposition of the great arteries 
(LTGA) and complete AV block39 (Figures 5A and 5B). 
This type of pacing was an attractive option, given the 
difficulty in cannulating the coronary sinus for CRT. 
Subsequent follow-up revealed no decrease in systemic 
ventricular systolic function despite chronic atrial fibril-
lation and 100% ventricular pacing (personal communi-
cation). Further studies are needed in those with CHD to 
better assess the feasibility and long-term outcomes for 
His-bundle pacing in this population.
Conclusions
His-bundle pacing has been consistently gaining popu-
larity in the adult population requiring CRT. Initial proce-
dural challenges are being overcome and this method of 
pacing has been shown to improve LV function and heart 
failure symptoms secondary to ventricular dyssynchrony. 
Although the etiologies of ventricular dyssynchrony may 
differ between children and those with CHD and adults 
with structurally normal hearts, His-bundle pacing may 
be a preferred option in these populations to restore more 
physiologic electric conduction and improve ventricular 
function.
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